Brain receives differing weather patterns from varying routes
In a groundbreaking study, researchers have revealed the complete sensory pathway for the skin to communicate cool temperatures to the brain, a discovery that could pave the way for new treatments for neuropathic pain.
The study, published on July 28, 2021, in the journal Nature Communications, marks the first time that this pathway has been mapped out. The researchers found specific sensors on the skin that are tuned to temperatures between 59 and 77 degrees Fahrenheit (15 to 25 degrees Celsius), which are considered cool.
These temperature-specific sensors, part of the research that earned the 2021 Nobel Prize in physiology or medicine, have a new discovered function: their signals get amplified in the spinal cord. In an experiment, disabling the cells responsible for this amplification in mice led to the rodents no longer reacting to cool temperatures.
The body differentiates between cool and warm temperatures through specialized sensory neurons in the skin called thermoreceptors. Warm temperatures activate warm-sensitive receptors like TRPV1-positive small-sized DRG neurons, which respond to heat and convey heat nociception (pain from noxious heat). Cool temperatures, on the other hand, activate distinct cold-sensitive neurons, often involving TRPM8 receptors.
In the spinal cord, the signals from these cold-sensitive neurons get amplified and passed along, ultimately activating neurons connected to the brain. These sensors excite sensory neurons when engaged, and the neurons then send signals to the spinal cord.
The researchers believe that the same temperature circuits are likely found in humans. This type of work may be helpful for pain relief in the context of medical procedures, such as reducing cold allodynia in cancer patients undergoing chemotherapy. The researchers hope to understand how the newly discovered cool-sensing pathway interacts with other sensory circuits, like those for pain and itch.
The study shows for the first time that different parts of the temperature spectrum use different circuits to alert the brain. There are still many sensory circuits in the brain that are not fully understood, and this study is an example of how mapping them can lead to exciting new discoveries. To answer these questions, the team plans to use advanced imaging techniques and genetic tools to explore this pathway in even greater detail.
In conditions like cold allodynia, innocuous cool sensations become painful, often due to nerve injury or sensitization of normally non-painful cold sensory neurons. This is a key feature in some neuropathic pain syndromes, burn injury-related pain, and complex regional pain syndrome (CRPS). Treatment approaches combine pharmacological and non-pharmacological methods, with drugs like amitriptyline, duloxetine, pregabalin, and gabapentin modulating nerve excitability. Topical treatments with lidocaine, menthol, or capsaicin can numb or alter peripheral nerve signaling.
Understanding the molecular mechanisms controlling thermal nociception, such as the regulation of receptors like TRPV1 and plasticity factors like histone lactylation, opens doors for more targeted therapies by modulating specific neuronal pathways or epigenetic regulation. In neuropathic conditions including CRPS, patients may present with "cold" type pain syndromes that often indicate chronicity and poorer prognosis, emphasizing the need for early and effective therapy to prevent progression.
The study was conducted on mice to understand how cool stimuli on the skin get translated into information the brain can digest and react to. This research represents an important shift in how we understand sensory perception, and the mouse study is just the first step in mapping these key sensory pathways in the brain. The researchers also want to learn how disruptions in these systems might contribute to temperature sensitivities.
The groundbreaking study in Nature Communications could potentially revolutionize health-and-wellness, as it provides insights into the treatment of neuropathic pain by unlocking the cool temperature sensory pathway in the human body. This newfound understanding of temperature-specific sensors, primarily functioning at temperatures between 59 and 77 degrees Fahrenheit, could pave the way for targeted therapies and treatments in the field of science.
The research, beyond its implications for pain relief during medical procedures, offers significant potential for addressing conditions like cold allodynia in individuals experiencing neuropathic pain syndromes, such as CRPS. The prospect of targeted therapies, modulating specific neuronal pathways or epigenetic regulation, could offer more effective and early intervention to prevent the progression of such conditions.
With a better comprehension of the cool-sensing pathway in the brain, scientists can now explore other sensory circuits, like those related to pain and itch, in the pursuit of a broader understanding of sensory perception and potential new treatments in the realm of health-and-wellness and therapies-and-treatments.
In addition, further exploration of this research could shed light on the origins of disruptions in these systems, contributing to temperature sensitivities, thereby opening new avenues for travel and exploration in science.
